Strong order book, soft execution—capacity ramp-up is the make-or-break

10% YoY is far below prior 35-40% FY27 guidance; QoQ fell 26.9%

Q1 standalone 15.6%, consolidated 19.2% (subsidiary boost); guidance 16% is flat vs prior 15-17% range

Changodar at 27% utilization Q1, expected 60-65% rest of year; unproven ramp timeline

Order book figure confirmed; 26% growth supports medium-term visibility

PAT down 4.7% YoY despite revenue +8.1% shows margin compression, not leverage

Prior call: 35-40% growth, ₹3,250 Cr target. New: 25% growth. Q1 delivered 8.1% YoY. Implies ~₹3,125 Cr FY27, well below prior aspiration.

Targetted 200-300 bps uplift now starts FY28 (from Q1 FY28 commissioning), not in FY27. Q1 standalone EBITDA 15.6% reflects absence of benefit.

Originally $1B; management cites rupee depreciation since prior call. Now targets ₹8,000 Cr by FY29 (vs ₹9,600 Cr at original $1B). Pathway clearer but target lower in rupees.

Prior: 15-17% stable with 150-300 bps expansion medium-term. New FY27: 16% standalone. No near-term accretion from backward integration.

Mainly Changodar expansion; new facilities start August '26. Raw materials sourced through December via bulk procurement. Geopolitical not a major headwind.

Temporary to protect against geopolitical risk until backward integration is live. Will reduce from Q4 FY28.

Confirmed 25% revenue, 16% EBITDA, 10% PAT margin. FY29: $1B (₹8,000 Cr). FY28 guidance in Q4 call.

Won via L1 bidding. ₹23,000 Cr inquiries under negotiation, 10-15% win ratio. Expect more such orders.

Q4 had ESOP and MD commission provisions. Q1 already accrued. No structural change.

16% EBITDA is consistent with FY26 full-year and Q4 FY27. This will continue.

Order book fairly spread 66-765 kV. This quarter heavier on 220/400/765 kV due to Changodar constraints. Will normalize post-Aug.

Yes, 200-300 bps from FY28 onwards. Facilities come up Q1-Q4 FY28. Depreciation will hit FY28.

Most orders still 18-24 months. PGCIL order exceptional, not trend. Win ratio 10-15% on ₹23,000 Cr pipeline.

Inventory temporary for geopolitical protection through December. Backward integration will reduce it from Q4 FY28.

16% includes other income, standalone transformer business. Consolidated may be 20-21% due to subsidiary.

Price variation clause protects. Also stocked inventory through December for large orders.

Finance lease ₹500 Cr of ₹1,000 Cr capex. Internal accruals + squeeze working capital cycle. Debt will not increase materially.

15-16 months to full manufacturing. 9 months to complete repair work. Then PGCIL trial order. Revenue 2027-28 onwards.

FY29 is earliest; path is ₹6,000 Cr transformer + ₹1,000 Cr backward integration = ₹8,000 Cr (≈$1B at current rupee). Rupee was different when prior target set.

No major reason. Will improve to 80-85% going forward. We are in line with market growth.

No possibility of margin decline. We are protected by ₹6,630 Cr order book.

Investigation ongoing, won't comment now. Protected our inventory until December. Things will get sorted by then.

FY27: 60-65%. FY28: 80-85% as backward integration comes online.

Major supplier 765 kV, 20+ years track record. Compete on quality, production capability, price. Will maintain 10-15% export mix.

Receivables reduced in April. Targeting 120-130 days working capital days going forward.

When $1B target set, rupee was low. Now targeting ₹8,000 Cr (≈$1B). From ₹5-6,000 Cr capacity + ₹800-1,000 Cr backward integration.

16% is standalone only. Subsidiary contributes ~100 bps uplift. Consolidated should be higher than FY26's 17.3%.

Geopolitical issues in past quarter; constrained at 57%. Now protected through December. Expect material improvement Q2 onwards.

Downgraded from prior 35-40% target (₹3,250 Cr). Contingent on Changodar ramp from 27% to 60-65% utilization by year-end and Moraiya reaching 80-85% FY28.

Path: ₹5-6,000 Cr from transformer expansion + ₹800-1,000 Cr from backward integration third-party sales. Rupee depreciation since prior $1B target set now makes target ₹8,000 Cr vs ₹9,600 Cr.

Flat vs prior 15-17% range. Q1 delivered 15.6% standalone (19.2% consolidated). No margin accretion until backward integration facilities live in FY28.

Q1 delivered 8.9% standalone. Guidance implies modest accretion from operational leverage and order mix, assuming Changodar ramp.

Starts Q1 FY28 as facilities come online. Gradual accretion as utilization scales. Depreciation impact will offset some benefit in FY28.

Delays already occurred (monsoon, labor, engineering enhancements). Now on 'revised execution schedule' per management.

Finance lease: ₹500 Cr. QIP proceeds: ₹145 Cr. Internal accruals + small debt if needed. To be funded mix of QIP, leasing, internal cash, minimal debt.

Changodar at 27% utilization, targeted 60-65% rest of FY27. Delayed plant commissioning history (monsoon, labor, engineering mods). Failure to ramp means ₹6,630 Cr order book execution delays and missed revenue targets.

Prior FY27 guidance 35-40% revenue growth downgraded to 25%; Q1 YoY only 8.1%, QoQ -26.9%. Implies sequential miss of ₹500-600 Cr annual revenue vs prior guide. Risk: further downgrades if Changodar ramp fails.

PAT -4.7% YoY despite revenue +8.1% signals margin squeeze. Q1 standalone EBITDA 15.6% below guidance 16%; PAT 8.9% vs FY27 target 9-10%. Risk: commodity inflation, unfavorable product mix (lower-rated units from Changodar when live), or pricing pressure.

CRGO steel imports subject to DGTR anti-dumping investigation; outcome uncertain. Geopolitical disruptions cited as reason for high inventory (₹561 Cr FY26, elevated in Q1). Risk: tariff imposition could add 5-10% to raw material costs if import-dependent sourced materials get hit.

₹900-1,000 Cr backward integration capex spanning CTC (Q2 FY27), Pressboard (Q3), Bushing (Q4), Fabrication (Q1 FY28). Prior history of delays at Changodar; margin benefit (200-300 bps) contingent on flawless ramp-up and market demand for 60-65% third-party sales.

Working capital cycle at 170 days (inventory 85 days, receivables 130 days). Inventory deliberately elevated through December 2026 for geopolitical protection; receivables elevated due to milestone-based billing of large transformer contracts. Risk: liquidity strain if order execution delays or receivables collection deteriorates.